← Leaderboards
Ashok Balasubramanyam
Baylor College Of Medicine
$21,769,207
Attributed
$24,605,668
Total exposure
34
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,949,116 · 35
By mechanism
U54$30,682,791 · 5
R01$8,001,243 · 5
R33$1,436,178 · 1
M01$943,558 · 22
R21$885,346 · 2
Top collaborators
- Jeffrey P Krischer9 shared
- Farook Jahoor5 shared
- Dorothy E Lewis5 shared
- Jerry P Palmer5 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Richard A Gibbs$598,461,520
- Jeffrey A Towbin$9,926,929
- James R. Lupski$27,260,466
- Dorothy E Lewis$6,936,067
- Farook Jahoor$8,036,031
Others in their field
Top investigators on “Insulin”
- Jeffrey P Krischer · University Of South Florida$605,714,892
- John M Lachin · George Washington University$153,440,346
- David M Nathan · Massachusetts Institute Of Technology$139,041,931
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Mark A Magnuson · Vanderbilt University$79,749,111
- Jose A Luchsinger · Columbia University Health Sciences$71,267,462
Research focus
InsulinBaseFunctional DisorderNon-Insulin-Dependent Diabetes MellitusObesityDiabetes MellitusPhenotypeSyndromeMetabolicResourcesInsulin-Dependent Diabetes MellitusFatty Acid Glycerol EstersMediatingMetabolomicsPlasmaResearch PersonnelInvestigationLipodystrophyEtiologyDefectFundingEnrollmentLipidsKinetics
Grant awards (74)
RARE and Atypical Diabetes Network(RADIANT)$2,500,000
U54 · FY2025 · DK · contact PI
RADIANT$1,086,232
U54 · FY2025 · DK · contact PI
RARE and Atypical Diabetes Network(RADIANT)$982,553
U54 · FY2025 · DK · contact PI
RARE and Atypical Diabetes Network(RADIANT)$226,483
U54 · FY2025 · DK · contact PI
RARE and Atypical Diabetes Network(RADIANT)$110,505
U54 · FY2025 · DK · contact PI
RARE and Atypical Diabetes Network(RADIANT)$2,500,000
U54 · FY2024 · DK · contact PI
RADIANT$1,066,134
U54 · FY2024 · DK · contact PI
RARE and Atypical Diabetes Network(RADIANT)$990,153
U54 · FY2024 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)$2,075,000
U54 · FY2023 · DK · contact PI
Discovery and Analysis Project$2,500,000
U54 · FY2022 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)$2,431,460
U54 · FY2022 · DK · contact PI
Discovery and Analysis Project$2,500,000
U54 · FY2020 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)$2,500,000
U54 · FY2020 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)$2,500,000
U54 · FY2019 · DK · contact PI
Discovery and Analysis Project$2,500,000
U54 · FY2019 · DK · contact PI
Role of Islet Injury and Autoimmunity in T2D Beta Cell Dysfunction$322,578
R01 · FY2019 · DK · contact PI
Center for Identification and Study of Individuals with Atypical Diabetes Mellitus (U54)$2,500,000
U54 · FY2018 · DK · contact PI
Discovery and Analysis Project$1,529,882
U54 · FY2018 · DK · contact PI
Adipose Tissue is a significant reservoir for HIV$469,726
R33 · FY2018 · AI
Arginine and Nitric Oxide Synthesis in the Pathogenesis of Ketosis-Prone Diabetes$359,643
R01 · FY2018 · DK
Role of Islet Injury and Autoimmunity in T2D Beta Cell Dysfunction$348,209
R01 · FY2018 · DK · contact PI
Administrative Core$184,389
U54 · FY2018 · DK · contact PI
Adipose Tissue is a significant reservoir for HIV$469,726
R33 · FY2017 · AI
Arginine and Nitric Oxide Synthesis in the Pathogenesis of Ketosis-Prone Diabetes$426,133
R01 · FY2017 · DK
Role of Islet Injury and Autoimmunity in T2D Beta Cell Dysfunction$353,493
R01 · FY2017 · DK · contact PI
Adipose Tissue is a significant reservoir for HIV$496,726
R33 · FY2016 · AI
Arginine and Nitric Oxide Synthesis in the Pathogenesis of Ketosis-Prone Diabetes$426,133
R01 · FY2016 · DK
Role of Islet Injury and Autoimmunity in T2D Beta Cell Dysfunction$350,073
R01 · FY2016 · DK · contact PI
Arginine and nitric oxide synthesis in the pathogenesis of ketosis-prone diabetes$426,133
R01 · FY2015 · DK
Role of Islet Injury and Autoimmunity in T2D Beta Cell Dysfunction$338,013
R01 · FY2015 · DK · contact PI
Adipose Tissue is a significant reservoir for HIV$213,927
R21 · FY2015 · AI
Arginine and nitric oxide synthesis in the pathogenesis of ketosis-prone diabetes$420,097
R01 · FY2014 · DK
Adipose Tissue is a significant reservoir for HIV$252,313
R21 · FY2014 · AI
Viral mechanisms of adipocyte dysfuntion: Role of Vpr.$438,674
R01 · FY2012 · DK · contact PI
Viral mechanisms of adipocyte dysfuntion: Role of Vpr.$452,133
R01 · FY2011 · DK · contact PI
PATHOGENESIS OF KETOSIS-PRONE DIABETES$21,766
M01 · FY2011 · RR · contact PI
THE EFFECT OF LEPTIN THERAPY ON LIPID METABOLISM IN HIV-LIPODYSTROPHY$7,036
M01 · FY2011 · RR · contact PI
DIET/EXERCISE, NIACIN, FENOFIBRATE FOR HIV LIPODYSTROPHY$1,760
M01 · FY2011 · RR · contact PI
ESTIMATION OF BETA CELL MASS EVOLUTION IN KETOSIS-PRONE DIABETES$792
M01 · FY2011 · RR · contact PI
Viral mechanisms of adipocyte dysfuntion: Role of Vpr.$505,325
R01 · FY2010 · DK · contact PI
Pathogenesis of Ketosis Prone Diabetes$177,706
R21 · FY2010 · DK · contact PI
DIET/EXERCISE, NIACIN, FENOFIBRATE FOR HIV LIPODYSTROPHY$32,941
M01 · FY2010 · RR · contact PI
Pathogenesis of Ketosis Prone Diabetes$26,000
R21 · FY2010 · DK · contact PI
PATHOGENESIS OF KETOSIS-PRONE DIABETES$17,931
M01 · FY2010 · RR · contact PI
THE EFFECT OF LEPTIN THERAPY ON LIPID METABOLISM IN HIV-LIPODYSTROPHY$15,646
M01 · FY2010 · RR · contact PI
ESTIMATION OF BETA CELL MASS EVOLUTION IN KETOSIS-PRONE DIABETES$7,631
M01 · FY2010 · RR · contact PI
Viral mechanisms of adipocyte dysfuntion: Role of Vpr.$503,522
R01 · FY2009 · DK · contact PI
Pathogenesis of Ketosis Prone Diabetes$215,400
R21 · FY2009 · DK · contact PI
DIET/EXERCISE, NIACIN, FENOFIBRATE FOR HIV LIPODYSTROPHY$111,039
M01 · FY2009 · RR · contact PI
THE EFFECT OF LEPTIN THERAPY ON LIPID METABOLISM IN HIV-LIPODYSTROPHY$29,080
M01 · FY2009 · RR · contact PI
DIET/EXERCISE, NIACIN, FENOFIBRATE FOR HIV LIPODYSTROPHY$148,265
M01 · FY2008 · RR · contact PI
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy$46,050
R01 · FY2008 · HL · contact PI
THE EFFECT OF LEPTIN THERAPY ON LIPID METABOLISM IN HIV-LIPODYSTROPHY$22,321
M01 · FY2008 · RR · contact PI
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy$264,279
R01 · FY2007 · HL · contact PI
DIET/EXERCISE, NIACIN, FENOFIBRATE FOR HIV LIPODYSTROPHY$102,483
M01 · FY2007 · RR · contact PI
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy$57,140
R01 · FY2007 · HL · contact PI
THE EFFECT OF LEPTIN THERAPY ON LIPID METABOLISM IN HIV-LIPODYSTROPHY$14,300
M01 · FY2007 · RR · contact PI
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy$264,279
R01 · FY2006 · HL · contact PI
DIET/EXERCISE, NIACIN, FENOFIBRATE FOR HIV LIPODYSTROPHY$68,217
M01 · FY2006 · RR · contact PI
THE EFFECT OF LEPTIN THERAPY ON LIPID METABOLISM IN HIV-LIPODYSTROPHY$44,828
M01 · FY2006 · RR · contact PI
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy$270,637
R01 · FY2005 · HL
THE EFFECT OF LEPTIN THERAPY ON LIPID METABOLISM IN HIV-LIPODYSTROPHY$31,245
M01 · FY2005 · RR
DIET/EXERCISE, NIACIN, FENOFIBRATE FOR HIV LIPODYSTROPHY$25,731
M01 · FY2005 · RR
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy$270,637
R01 · FY2004 · HL
Growth Hormone Therapy in HIV Lipodystrophy Syndrome$18,167
M01 · FY2004 · RR
LEPTIN THERAPYEFFECT ON LIPID METABOLISM IN HIV-LIPODYST$15,899
M01 · FY2004 · RR
PATHOGENESIS OF HIV PROTEASE INHIBITOR METABOLIC SYNDROME$12,492
M01 · FY2004 · RR
PATHOGENESIS OF HIV - ASSOCIATED LIPODYSTROPHY SYNDROME$2,272
M01 · FY2004 · RR
MOLECULAR BASIS OF HIV LIPODYSTROPHY: ROLE OF VPR$291,600
R01 · FY2003 · DK
Diet/Exercise, Niacin, Fenofibrate for HIV Lipodystrophy$283,262
R01 · FY2003 · HL
MOLECULAR BASIS OF HIV LIPODYSTROPHY: ROLE OF VPR$291,600
R01 · FY2002 · DK
MOLECULAR BASIS OF HIV LIPODYSTROPHY: ROLE OF VPR$291,600
R01 · FY2001 · DK
POSTPRANDIAL GLUCONEOGENESIS TO GLUCOSE PRODUCTION IN NORMAL VS NIDDM$155,764
M01 · FY2001 · RR
POSTPRANDIAL GLUCONEOGENESIS TO GLUCOSE PRODUCTION IN NORMAL VS NIDDM$35,952
M01 · FY2000 · RR